09:52 AM EST - Theralase Technologies Inc. : Has submitted its anti-cancer technology to the Research Ethics Board of Princess Margaret Cancer Centre, University Health Network for approval. Theralase Technologies Inc.
shares V.TLT are trading down $0.02 at $0.34.
